Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2012
03/01/2012US20120052572 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
03/01/2012US20120052571 Differentiation of Human Embryonic Stem Cells
03/01/2012US20120052570 Method for temporally controlling the biological activity of proteins in vertebrates, and applications thereof
03/01/2012US20120052569 Tag peptide having a protease recognition sequence and use thereof
03/01/2012US20120052568 Non-Static Suspension Culture of Cell Aggregates
03/01/2012US20120052567 Microstructure for Particle and Cell Separation, Identification, Sorting, and Manipulation
03/01/2012US20120052566 Anti-vegf-c antibodies and methods using same
03/01/2012US20120052553 Multiply-Substituted Protease Variants
03/01/2012US20120052549 Mutant hpgg motif and hdash motif delta-5 desaturases and their use in making polyunsaturated fatty acids
03/01/2012US20120052544 Enucleation of cells with psoralens
03/01/2012US20120052533 4s-iota-carrageenan sulfatase and use thereof to obtain alpha-carrageenan
03/01/2012US20120052529 Episomal expression vector for metazoan cells
03/01/2012US20120052525 Polymers for growing cells
03/01/2012US20120052517 Methods for testing an immune response using cultures of t cells, b cells and dendritic cells
03/01/2012US20120052511 Methods for controlling pore morphology in aerogels using electric fields and products thereof
03/01/2012US20120052485 Sperm separation system
03/01/2012US20120052479 Methods, compositions and devices for inducing stasis in tissues and organs
03/01/2012US20120052136 Novel heamoglobin and uses thereof
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052073 Antibodies Directed to Angiopoietin-2 And Uses Thereof
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052059 Regulatory b cells and their use
03/01/2012US20120052043 Chemokine-Chaperone Fusion Proteins
03/01/2012US20120051970 Process for creating acellular viable donor soft tissue
03/01/2012DE102010035702A1 Ganzzell-Biokatalysator Whole-cell biocatalyst
03/01/2012CA2842181A1 Bone marrow derived cd271 precursor cells for cardiac repair
03/01/2012CA2841641A1 In vitro hepatic differentiation
03/01/2012CA2809498A1 Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression
03/01/2012CA2809433A1 Dual variable domain immunoglobulins and uses thereof
03/01/2012CA2809415A1 Cell-protective peptides and uses thereof
03/01/2012CA2809367A1 Basement membrane compositions and applications thereof
03/01/2012CA2809245A1 Non-static suspension culture of cell aggregates
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
02/2012
02/29/2012EP2423311A1 Method for preparing cell pharmaceutical
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2423309A1 Method for preparing cell highly producing heterogeneous protein
02/29/2012EP2423303A1 Method to modulate hematopoietic stem cell growth
02/29/2012EP2423302A1 New serum-free medium for inducing pluripotent stem cells quickly with high efficiency and method using thereof
02/29/2012EP2423231A2 PRLR-specific antibody and uses thereof
02/29/2012EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein
02/29/2012EP2422803A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422802A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422801A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422800A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422799A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422798A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422797A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422796A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422795A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422794A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
02/29/2012EP2422622A1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
02/29/2012EP2422200A2 Methods and systems for identifying immunomodulatory substances
02/29/2012EP2422003A1 Interactive microenvironment system
02/29/2012EP2421985A1 Yield enhancement in plants by modulation of a maize transcription coactivator p15 (pc4) protein
02/29/2012EP2421959A1 Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney
02/29/2012EP2421958A1 Methods for mitochondrial dna replacement in oocytes
02/29/2012EP2421957A2 Cell compositions derived from dedifferentiated reprogrammed cells
02/29/2012EP2421956A2 Compositions and methods for deriving or culturing pluripotent cells
02/29/2012EP2421955A1 Methods for obtaining fetal genetic material
02/29/2012EP2421954A1 Differentiated human liver cell cultures and their use in bioartificial liver systems
02/29/2012EP2421953A1 Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6
02/29/2012EP2421952A2 Compositions for transfection of biomolecules into cells
02/29/2012EP2421892A1 Control of protein glycosylation and compositions and methods relating thereto
02/29/2012EP2421467A1 Methods of making and using three-dimensional extracellular matrices
02/29/2012EP2421360A1 A sperm separation system
02/29/2012EP2040719B1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
02/29/2012EP1928249B1 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof
02/29/2012EP1831353B1 Non-tumorigenic mdck cell line for propagating viruses
02/29/2012EP1767639B1 Oral anti-leucocytozoonosis vaccines based on transgenic plants
02/29/2012EP1670826B1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
02/29/2012EP1419255B1 A novel group of alpha-amylases and a method for identification and production of novel alpha-amylases
02/29/2012EP1343875B1 Sugar beet genes involved in stress tolerance
02/29/2012EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus
02/29/2012EP1002091B1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
02/29/2012CN1968713B Method of regenerating follicles by inhibiting gene capable of inhibiting follicle formation or activating gene capable of inducing follicle formation
02/29/2012CN1914223B Modified human interferon polypeptides and their uses
02/29/2012CN1351656B Human liver progenitors
02/29/2012CN102365361A Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
02/29/2012CN102363768A Soybean lipoxygenase isozyme resisting monoclonal antibody hybridoma cell lines, and antibody and application thereof
02/29/2012CN102363767A Neuron-like cells obtained by processing neural stem cells by use of saikoside alpha, development of kit thereof and composition for treating nervous system diseases
02/29/2012CN102363766A Method for promoting in vitro maturation of immature oocytes by using activin A (ActA)
02/29/2012CN102363765A Technological method for promoting ectogenesis of premeiotic female germ cells by using activin A (ActA)
02/29/2012CN102363764A Method for cultivating pancreatic stem/progenitor cells
02/29/2012CN102363632A Pesticide Bt protein Cry8Kb1 and coding gene and use thereof
02/29/2012CN102363631A Insecticidal Bt (Bacillus thuringiensis) protein Cry8Qa1, coding gene thereof and application thereof
02/29/2012CN102363630A Pesticide Bt protein Cry8Pa1 and coding gene and use thereof
02/29/2012CN102119657B Tender stem callus plant regeneration induction culture medium for lonicera caerulea
02/29/2012CN101993854B Colorectal carcinoma cell line CJF from hepatic metastasis and construction method thereof
02/29/2012CN101942424B Coding gene of UDP (Uridine Diphosphate)-glucosyltransferase mutant and application thereof
02/29/2012CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof
02/29/2012CN101892252B Gene for encoding muramidase and application of same
02/29/2012CN101880677B siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof
02/29/2012CN101580816B Novel serum-free culture medium for inducing fast and efficient production of pluripotent stem cells and use method thereof
02/29/2012CN101570575B Sncg monoclonal antibody and application thereof
02/29/2012CN101307302B Process for preparing hybridoma cell for secreting anti-human asparagine hydroxylase monoclonal antibodies
02/28/2012US8124858 Maize variety hybrid 10126280
02/28/2012US8124855 Plants and seeds of hybrid corn variety CH747345